DTX1 (E3 ubiquitin-protein ligase DTX1) variants and mutations
DTX1 (also known as E3 ubiquitin-protein ligase DTX1) is a human protein-coding gene encoding an e3 ubiquitin-protein ligase protein. It modifies Notch and other signaling proteins through ubiquitination and helps tune lymphocyte activation and differentiation. Somatic loss-of-function alterations are recurrent in B-cell lymphomas and can disturb normal immune-signaling programs. This analysis covers 1,095 DTX1 variants and mutations. Of these, 96% have computational variant effect predictions. Disease context includes Abnormality of the skeletal system, myocardial infarction, and liver disorder. Example DTX1 variants include S2L, S2P, and R3G.
Variant analysis overview
- Gene: DTX1
- Protein: E3 ubiquitin-protein ligase DTX1
- UniProt accession: Q86Y01
- Organism: Homo sapiens
- Variants analyzed: 1095
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 783 unspecified-consequence records; 110 synonymous variants; 147 missense variants; 7 in-frame deletions; 30 frameshift variants; 13 stop-gained variants; 2 splice-region variants; 3 in-frame insertions
- Prediction scores: 1,054 variants have prediction scores (96% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Abnormality of the skeletal system, myocardial infarction, liver disorder, angina pectoris, gout, carcinoma of esophagus, colorectal cancer, polyp of colon, cirrhosis of liver, B-cell chronic lymphocytic leukemia, neoplasm, osteosarcoma.
Protein structure and variant hotspots
- Protein features: 2 domains.
- Structural context: 536 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable DTX1 variants
Examples include S2L, S2P, R3G, R3Q, R3W, R3R, R3P, P4A. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2L (p.Ser2Leu), ExAC rs756300071, gnomAD rs756300071, MetaLR 0.03, MetaSVM -1.08
- S2P (p.Ser2Pro), gnomAD rs1376411592, MetaLR 0.03, MetaSVM -1.05
- R3G (p.Arg3Gly), ExAC rs777879482, TOPMed rs777879482, gnomAD rs777879482, MetaLR 0.06, MetaSVM -1.12
- R3Q (p.Arg3Gln), Ensembl rs2044642520, MetaLR 0.05, MetaSVM -1.08
- R3W (p.Arg3Trp), ExAC rs777879482, TOPMed rs777879482, gnomAD rs777879482, MetaLR 0.06, MetaSVM -1.12
- R3R (p.Arg3Arg), gnomAD 12-113058199-C-A, CADD 12.90
- R3P (p.Arg3Pro), gnomAD 12-113058200-G-C, MetaLR 0.07, MetaSVM -1.09
- P4A (p.Pro4Ala), Ensembl rs2044642553, MetaLR 0.08, MetaSVM -1.09
- G5G (p.Gly5Gly), rs1398441840, gnomAD 12-113058207-C-T, CADD 12.60
- H6P (p.His6Pro), 1000Genomes rs749069556, ExAC rs749069556, gnomAD rs749069556, MetaLR 0.01, MetaSVM -0.95
- H6Y (p.His6Tyr), ESP rs373827220, gnomAD rs373827220, MetaLR 0.02, MetaSVM -1.02
- H6H (p.His6His), rs377259444, gnomAD 12-113058210-C-T, CADD 7.03
- G7R (p.Gly7Arg), Ensembl rs1592839080, MetaLR 0.09, MetaSVM -1.06
- G7C (p.Gly7Cys), gnomAD 12-113058211-G-T, MetaLR 0.09, MetaSVM -1.06
- G7S (p.Gly7Ser), gnomAD 12-113058211-G-A, MetaLR 0.07, MetaSVM -1.13
- G7G (p.Gly7Gly), rs757042093, gnomAD 12-113058213-T-C, CADD 6.11
- G8W (p.Gly8Trp), gnomAD 12-113058214-G-T, MetaLR 0.02, MetaSVM -1.00
- G8E (p.Gly8Glu), gnomAD 12-113058215-G-A, MetaLR 0.01, MetaSVM -0.97
- G8G (p.Gly8Gly), gnomAD 12-113058216-G-T, CADD 9.32
- L9P (p.Leu9Pro), Ensembl rs2044642782, MetaLR 0.04, MetaSVM -1.10
- L9L (p.Leu9Leu), rs2044642761, gnomAD 12-113058217-C-T, CADD 8.17
- M10L (p.Met10Leu), TOPMed rs1298847491, gnomAD rs1298847491, MetaLR 0.01, MetaSVM -0.95
- M10T (p.Met10Thr), 1000Genomes rs200824699, ExAC rs200824699, TOPMed rs200824699, gnomAD rs200824699, MetaLR 0.02, MetaSVM -1.00
- M10V (p.Met10Val), TOPMed rs1298847491, gnomAD rs1298847491, MetaLR 0.01, MetaSVM -0.94
- P11L (p.Pro11Leu), ExAC rs771706036, gnomAD rs771706036, MetaLR 0.03, MetaSVM -1.09
- P11S (p.Pro11Ser), rs545955103, 1000Genomes rs545955103, ExAC rs545955103, gnomAD rs545955103, MetaLR 0.02, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- P11T (p.Pro11Thr), 1000Genomes rs545955103, ExAC rs545955103, gnomAD rs545955103, MetaLR 0.02, MetaSVM -1.06
- P11P (p.Pro11Pro), rs775076085, gnomAD 12-113058225-T-C, CADD 3.72
- V12M (p.Val12Met), TOPMed rs2044642933, MetaLR 0.03, MetaSVM -1.06
- V12V (p.Val12Val), gnomAD 12-113058228-G-T, CADD 8.49
- N13I (p.Asn13Ile), ExAC rs746517355, MetaLR 0.02, MetaSVM -1.10
- N13S (p.Asn13Ser), ExAC rs746517355, MetaLR 0.02, MetaSVM -0.89
- p.Asn13 Gly14del, rs2044642959, gnomAD 12-113058228-GAAT, CADD 20.70
- N13K (p.Asn13Lys), gnomAD 12-113058231-T-A, MetaLR 0.02, MetaSVM -1.06
- G14S (p.Gly14Ser), ExAC rs768309364, gnomAD rs768309364, MetaLR 0.04, MetaSVM -1.03
- L15H (p.Leu15His), gnomAD 12-113058234-TCTG, CADD 29.90
- L15L (p.Leu15Leu), rs1263444536, gnomAD 12-113058235-C-T, CADD 13.10
- G16A (p.Gly16Ala), ExAC rs776182768, gnomAD rs776182768, MetaLR 0.02, MetaSVM -1.01
- G16D (p.Gly16Asp), ExAC rs776182768, gnomAD rs776182768, MetaLR 0.03, MetaSVM -1.10
- G16G (p.Gly16Gly), gnomAD 12-113058240-C-T, CADD 14.20
- F17L (p.Phe17Leu), gnomAD rs1190990812, MetaLR 0.02, MetaSVM -1.00
- F17C (p.Phe17Cys), gnomAD 12-113058242-T-G, MetaLR 0.04, MetaSVM -1.10
- P18A (p.Pro18Ala), ExAC rs763349356, TOPMed rs763349356, gnomAD rs763349356, MetaLR 0.02, MetaSVM -1.09
- P18H (p.Pro18His), gnomAD 12-113058242-TC-T, CADD 26.00
- P18S (p.Pro18Ser), gnomAD 12-113058244-C-T, MetaLR 0.03, MetaSVM -1.07
- P19L (p.Pro19Leu), TOPMed rs1213905795, gnomAD rs1213905795, MetaLR 0.03, MetaSVM -1.06
- P19S (p.Pro19Ser), ExAC rs766783302, TOPMed rs766783302, gnomAD rs766783302, MetaLR 0.02, MetaSVM -1.06
- P19P (p.Pro19Pro), rs774831457, gnomAD 12-113058249-G-C, CADD 9.98
- Q20E (p.Gln20Glu), gnomAD rs2044643260, MetaLR 0.03, MetaSVM -1.08
- Q20P (p.Gln20Pro), gnomAD rs2044643291, MetaLR 0.03, MetaSVM -1.06
- N21K (p.Asn21Lys), ExAC rs768022485, gnomAD rs768022485, MetaLR 0.02, MetaSVM -1.04
- N21S (p.Asn21Ser), TOPMed rs1009981596, gnomAD rs1009981596, MetaLR 0.01, MetaSVM -0.97
- N21T (p.Asn21Thr), TOPMed rs1009981596, gnomAD rs1009981596, MetaLR 0.03, MetaSVM -1.08
- N21N (p.Asn21Asn), gnomAD 12-113058255-C-T, CADD 5.74
- V22L (p.Val22Leu), rs752771858, ClinGen CA386816874, ClinVar RCV004363929, ExAC rs752771858, MetaLR 0.02, MetaSVM -1.00, Uncertain significance, not specified
- V22M (p.Val22Met), ExAC rs752771858, TOPMed rs752771858, gnomAD rs752771858, MetaLR 0.02, MetaSVM -1.00, Uncertain significance
- A23V (p.Ala23Val), gnomAD 12-113058260-C-T, MetaLR 0.15, MetaSVM -0.94
- R24Q (p.Arg24Gln), TOPMed rs2044643399, gnomAD rs2044643399, MetaLR 0.16, MetaSVM -0.97
- R24P (p.Arg24Pro), gnomAD 12-113058263-G-C, MetaLR 0.21, MetaSVM -0.81
- R24R (p.Arg24Arg), rs756177831, gnomAD 12-113058264-G-C, CADD 13.10
- V25E (p.Val25Glu), NCI-TCGA Cosmic COSV5749, MetaLR 0.22, MetaSVM -0.64, Variant assessed as somatic; moderate impact.
- V25M (p.Val25Met), gnomAD rs2044643460, MetaLR 0.29, MetaSVM -0.39
- V25L (p.Val25Leu), gnomAD 12-113058265-G-T, MetaLR 0.31, MetaSVM -0.30
- V25V (p.Val25Val), gnomAD 12-113058267-G-T, CADD 11.30
- V26E (p.Val26Glu), Ensembl rs2136420668, MetaLR 0.30, MetaSVM -0.39
- V26M (p.Val26Met), gnomAD 12-113058268-G-A, MetaLR 0.32, MetaSVM -0.29
- V26L (p.Val26Leu), gnomAD 12-113058268-G-C, MetaLR 0.31, MetaSVM -0.31
- V26V (p.Val26Val), rs2136420672, gnomAD 12-113058270-G-A, CADD 12.70
- V27M (p.Val27Met), gnomAD 12-113058271-G-A, MetaLR 0.31, MetaSVM -0.32
- V27A (p.Val27Ala), gnomAD 12-113058272-T-C, MetaLR 0.32, MetaSVM -0.31
- V27V (p.Val27Val), rs764344755, gnomAD 12-113058273-G-T, CADD 9.32
- W28* (p.Trp28Ter), NCI-TCGA Cosmic COSV5749, Variant assessed as somatic; high impact.
- W28S (p.Trp28Ser), ExAC rs754056155, gnomAD rs754056155, MetaLR 0.86, MetaSVM 0.90
- W28R (p.Trp28Arg), gnomAD 12-113058274-T-C, MetaLR 0.86, MetaSVM 0.90
- E29G (p.Glu29Gly), rs1457536266, gnomAD 12-113058276-GGAG, CADD 32.00
- E29D (p.Glu29Asp), gnomAD 12-113058279-G-T, MetaLR 0.31, MetaSVM -0.25
- W30* (p.Trp30Ter), 1000Genomes rs1369400654, gnomAD rs1369400654, CADD 38.00
- W30R (p.Trp30Arg), gnomAD rs1291601450, NCI-TCGA Cosmic COSV5750, MetaLR 0.37, MetaSVM -0.16, Variant assessed as somatic; moderate impact.
- L31P (p.Leu31Pro), gnomAD rs1308401995, MetaLR 0.21, MetaSVM -0.71
- L31V (p.Leu31Val), ExAC rs757104501, gnomAD rs757104501, MetaLR 0.12, MetaSVM -0.94
- L31L (p.Leu31Leu), rs757104501, gnomAD 12-113058283-C-T, CADD 12.50
- N32D (p.Asn32Asp), Ensembl rs1592839146, MetaLR 0.06, MetaSVM -1.06
- N32I (p.Asn32Ile), 1000Genomes rs968368004, TOPMed rs968368004, gnomAD rs968368004, MetaLR 0.20, MetaSVM -0.80
- N32S (p.Asn32Ser), 1000Genomes rs968368004, TOPMed rs968368004, gnomAD rs968368004, MetaLR 0.08, MetaSVM -1.06
- N32N (p.Asn32Asn), gnomAD 12-113058288-T-C, CADD 6.24
- E33D (p.Glu33Asp), gnomAD 12-113058291-G-C, MetaLR 0.08, MetaSVM -0.99
- E33E (p.Glu33Glu), rs778919730, gnomAD 12-113058291-G-A, CADD 10.60
- H34N (p.His34Asn), gnomAD rs1241663277, MetaLR 0.06, MetaSVM -1.08
- H34P (p.His34Pro), ExAC rs201878530, TOPMed rs201878530, gnomAD rs201878530, MetaLR 0.15, MetaSVM -0.93, Uncertain significance, not specified
- H34Y (p.His34Tyr), gnomAD rs1241663277, MetaLR 0.08, MetaSVM -1.03
- H34H (p.His34His), rs758355234, gnomAD 12-113058294-C-T, CADD 12.30
- S35T (p.Ser35Thr), Ensembl rs1027786212, MetaLR 0.10, MetaSVM -0.79
- S35G (p.Ser35Gly), gnomAD 12-113058295-A-G, MetaLR 0.02, MetaSVM -1.00
- S35R (p.Ser35Arg), gnomAD 12-113058297-C-A, MetaLR 0.09, MetaSVM -0.99
- R36C (p.Arg36Cys), Ensembl rs958902509, MetaLR 0.23, MetaSVM -0.71
- R36H (p.Arg36His), rs1264108701, NCI-TCGA Cosmic COSV5750, gnomAD rs1264108701, MetaLR 0.16, MetaSVM -0.97, Variant assessed as somatic; moderate impact.
- R36R (p.Arg36Arg), rs1288136306, gnomAD 12-113058300-C-T, CADD 14.00
- W37* (p.Trp37Ter), gnomAD 12-113058302-G-A, CADD 37.00
- W37S (p.Trp37Ser), gnomAD 12-113058302-G-C, MetaLR 0.81, MetaSVM 0.85
- R38G (p.Arg38Gly), NCI-TCGA Cosmic COSV9998, 1000Genomes rs1489654894, gnomAD rs1489654894, MetaLR 0.28, MetaSVM -0.50, Variant assessed as somatic; moderate impact.
- R38Q (p.Arg38Gln), ESP rs147326535, TOPMed rs147326535, gnomAD rs147326535, MetaLR 0.31, MetaSVM -0.36
- R38W (p.Arg38Trp), rs1489654894, NCI-TCGA Cosmic COSV9998, 1000Genomes rs1489654894, gnomAD rs1489654894, MetaLR 0.22, MetaSVM -0.68, Variant assessed as somatic; moderate impact.
- P39A (p.Pro39Ala), Ensembl rs1592839173, MetaLR 0.26, MetaSVM -0.55
- P39P (p.Pro39Pro), rs1238091268, gnomAD 12-113058309-C-T, CADD 13.60
- Y40F (p.Tyr40Phe), Ensembl rs2136420713, MetaLR 0.53, MetaSVM 0.16
- Y40H (p.Tyr40His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y40N (p.Tyr40Asn), NCI-TCGA TCGA novel, MetaLR 0.62, MetaSVM 0.38, Variant assessed as somatic; moderate impact.
- Y40T (p.Tyr40Thr), gnomAD 12-113058309-CT-C, CADD 28.10
- Y40Y (p.Tyr40Tyr), rs780164893, gnomAD 12-113058312-C-T, CADD 9.81
- T41M (p.Thr41Met), rs979063266, NCI-TCGA Cosmic COSV5749, TOPMed rs979063266, gnomAD rs979063266, MetaLR 0.16, MetaSVM -0.61, Variant assessed as somatic; moderate impact.
- T41P (p.Thr41Pro), gnomAD 12-113058313-A-C, MetaLR 0.11, MetaSVM -0.81
- T41T (p.Thr41Thr), rs370359657, gnomAD 12-113058315-G-A, CADD 7.88
- A42T (p.Ala42Thr), ExAC rs776328674, gnomAD rs776328674, MetaLR 0.13, MetaSVM -0.92
- A42V (p.Ala42Val), rs2541086398, ClinGen CA386817380, ClinVar RCV004355164, NCI-TCGA TCGA novel, Uncertain significance, not specified
- A42A (p.Ala42Ala), rs1268184778, gnomAD 12-113058318-C-T, CADD 11.30
- T43A (p.Thr43Ala), ExAC rs747818661, gnomAD rs747818661, MetaLR 0.03, MetaSVM -1.02
- T43T (p.Thr43Thr), rs769437286, gnomAD 12-113058321-C-A, CADD 4.57
- V44A (p.Val44Ala), 1000Genomes rs199944169, ExAC rs199944169, TOPMed rs199944169, gnomAD rs199944169, MetaLR 0.27, MetaSVM -0.50
- V44M (p.Val44Met), ExAC rs774637405, gnomAD rs774637405, MetaLR 0.34, MetaSVM -0.20
- V44L (p.Val44Leu), gnomAD 12-113058322-G-T, MetaLR 0.31, MetaSVM -0.32
- C45* (p.Cys45Ter), ExAC rs767971099, TOPMed rs767971099, gnomAD rs767971099, CADD 35.00
- C45C (p.Cys45Cys), rs767971099, gnomAD 12-113058327-C-T, CADD 11.60
- H46Q (p.His46Gln), ExAC rs775900132, gnomAD rs775900132, MetaLR 0.13, MetaSVM -0.99
- H46H (p.His46His), rs775900132, gnomAD 12-113058330-C-T, CADD 9.72
- H47D (p.His47Asp), gnomAD 12-113058331-C-G, MetaLR 0.24, MetaSVM -0.61
- I48T (p.Ile48Thr), gnomAD rs2044644421, MetaLR 0.44, MetaSVM -0.03
- I48I (p.Ile48Ile), rs760786131, gnomAD 12-113058336-T-C, CADD 8.75
- E49V (p.Glu49Val), gnomAD 12-113058338-A-T, MetaLR 0.46, MetaSVM 0.04
- E49E (p.Glu49Glu), rs2136420741, gnomAD 12-113058339-G-A, CADD 9.00
- E49D (p.Glu49Asp), gnomAD 12-113058339-G-T, MetaLR 0.34, MetaSVM -0.37
- N50S (p.Asn50Ser), Ensembl rs2044644468, MetaLR 0.11, MetaSVM -0.96
- N50T (p.Asn50Thr), gnomAD 12-113058341-A-C, MetaLR 0.11, MetaSVM -0.97
- N50N (p.Asn50Asn), rs2044644493, gnomAD 12-113058342-C-T, CADD 2.73
- V51M (p.Val51Met), rs868570524, NCI-TCGA Cosmic COSV5750, gnomAD rs868570524, MetaLR 0.20, MetaSVM -0.75, Variant assessed as somatic; moderate impact.
- V51L (p.Val51Leu), gnomAD 12-113058343-G-T, MetaLR 0.12, MetaSVM -0.97
- V51V (p.Val51Val), rs201619192, gnomAD 12-113058345-G-C, CADD 10.20
- L52R (p.Leu52Arg), TOPMed rs1434322197, gnomAD rs1434322197, MetaLR 0.11, MetaSVM -0.98
- L52V (p.Leu52Val), NCI-TCGA TCGA novel, MetaLR 0.08, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- L52L (p.Leu52Leu), gnomAD 12-113058346-C-T, CADD 12.60
- K53R (p.Lys53Arg), Ensembl rs2044644593, MetaLR 0.04, MetaSVM -1.03
- K53K (p.Lys53Lys), gnomAD 12-113058351-G-A, CADD 11.90
- E54D (p.Glu54Asp), NCI-TCGA Cosmic COSV5750, Variant assessed as somatic; moderate impact.
- E54K (p.Glu54Lys), Ensembl rs867323454, MetaLR 0.06, MetaSVM -1.04
- E54* (p.Glu54Ter), gnomAD 12-113058352-G-T, CADD 36.00
- D55A (p.Asp55Ala), gnomAD rs1279657069
- D55E (p.Asp55Glu), ESP rs374367644, ExAC rs374367644, TOPMed rs374367644, gnomAD rs374367644, MetaLR 0.17, MetaSVM -0.79
- D55G (p.Asp55Gly), gnomAD rs1279657069, MetaLR 0.13, MetaSVM -1.03
- D55D (p.Asp55Asp), rs374367644, gnomAD 12-113058357-C-T, CADD 2.81
- A56P (p.Ala56Pro), ExAC rs200220437, gnomAD rs200220437, MetaLR 0.05, MetaSVM -1.08
- A56S (p.Ala56Ser), ExAC rs200220437, gnomAD rs200220437, MetaLR 0.09, MetaSVM -0.97
- A56T (p.Ala56Thr), rs200220437, NCI-TCGA Cosmic COSV5750, ExAC rs200220437, gnomAD rs200220437, MetaLR 0.09, MetaSVM -0.97, Variant assessed as somatic; moderate impact.
- A56V (p.Ala56Val), rs1314428665, gnomAD rs1314428665, MetaLR 0.09, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- R57C (p.Arg57Cys), NCI-TCGA Cosmic COSV9998, MetaLR 0.28, MetaSVM -0.51, Variant assessed as somatic; moderate impact.
- R57H (p.Arg57His), rs1337481570, NCI-TCGA Cosmic COSV5749, TOPMed rs1337481570, gnomAD rs1337481570, MetaLR 0.23, MetaSVM -0.68, Variant assessed as somatic; moderate impact.
- R57R (p.Arg57Arg), rs139419148, gnomAD 12-113058363-C-T, CADD 1.63
- G58A (p.Gly58Ala), NCI-TCGA Cosmic COSV5749, MetaLR 0.22, MetaSVM -0.79, Variant assessed as somatic; moderate impact.
- G58D (p.Gly58Asp), gnomAD rs1456848938, MetaLR 0.19, MetaSVM -0.86
- G58S (p.Gly58Ser), rs201380111, ClinGen CA6801743, NCI-TCGA Cosmic COSV5749, ClinVar RCV004196932, MetaLR 0.17, MetaSVM -0.95, Uncertain significance, not specified
- G58V (p.Gly58Val), gnomAD rs1456848938, MetaLR 0.29, MetaSVM -0.45
- G58R (p.Gly58Arg), gnomAD 12-113058364-G-C, MetaLR 0.25, MetaSVM -0.55
- G58G (p.Gly58Gly), rs1203061411, gnomAD 12-113058366-T-C, CADD 7.07
- S59A (p.Ser59Ala), 1000Genomes rs1592839246, MetaLR 0.13, MetaSVM -0.90
- S59F (p.Ser59Phe), gnomAD rs1201021667, MetaLR 0.21, MetaSVM -0.84
- S59Y (p.Ser59Tyr), gnomAD 12-113058368-C-A, MetaLR 0.22, MetaSVM -0.84
- S59S (p.Ser59Ser), rs758302185, gnomAD 12-113058369-C-T, CADD 4.95
- V60A (p.Val60Ala), ExAC rs780013460, TOPMed rs780013460, gnomAD rs780013460, MetaLR 0.32, MetaSVM -0.30
- V60E (p.Val60Glu), ExAC rs780013460, TOPMed rs780013460, gnomAD rs780013460, MetaLR 0.37, MetaSVM -0.19
- V60M (p.Val60Met), Ensembl rs1566011799, MetaLR 0.38, MetaSVM -0.09
- V60L (p.Val60Leu), gnomAD 12-113058370-G-T, MetaLR 0.26, MetaSVM -0.58
- V60V (p.Val60Val), gnomAD 12-113058372-G-T, CADD 11.40
- V61A (p.Val61Ala), gnomAD rs1416209035
- V61F (p.Val61Phe), gnomAD rs1180404140, MetaLR 0.15, MetaSVM -0.86
- V61G (p.Val61Gly), gnomAD rs1416209035, MetaLR 0.07, MetaSVM -1.10
- V61I (p.Val61Ile), gnomAD rs1180404140, MetaLR 0.13, MetaSVM -0.83
- V61V (p.Val61Val), gnomAD 12-113058375-C-G, CADD 10.10
- L62M (p.Leu62Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L62P (p.Leu62Pro), Ensembl rs1566011809, AlphaMissense 1.00, MetaLR 0.48
- L62R (p.Leu62Arg), rs1566011809, Ensembl rs1566011809, AlphaMissense 1.00, MetaLR 0.48, Variant assessed as somatic; moderate impact.
- L62L (p.Leu62Leu), rs1475623744, gnomAD 12-113058378-G-C, CADD 12.20
- G63R (p.Gly63Arg), NCI-TCGA TCGA novel, MetaLR 0.28, MetaSVM -0.40, Variant assessed as somatic; moderate impact.
Public DTX1 analysis runs
- DTX1 analysis run — DTX1 (1,095 variants) — completed 2026-08-18
- DTX1 analysis run — DTX1 (1,095 variants) — completed 2026-08-18